BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25838250)

  • 1. Expression of CBY and methylation of CBY at promoter region in human laryngeal squamous cell carcinoma.
    Ren G; Zhao DA; Xu J; Li BA
    Tumori; 2015; 101(2):215-22. PubMed ID: 25838250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulated Chibby in laryngeal squamous cell carcinoma with increased expression in laryngeal carcinoma Hep-2 cells.
    Xu J; Ren G; Zhao DA; Li BA; Cai CF; Zhou Y; Luo XY
    Oncol Rep; 2014 Nov; 32(5):1947-56. PubMed ID: 25175341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma.
    Yang M; Li W; Liu YY; Fu S; Qiu GB; Sun KL; Fu WN
    BMC Cancer; 2012 Jun; 12():219. PubMed ID: 22672838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of mRNA expression level and hypermethylation of CHFR promoter in the laryngeal squamous cell carcinoma tissue].
    He L; Ji W; Yang J; Zhao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):673-7. PubMed ID: 20942233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.
    Shen Z; Lin L; Cao B; Zhou C; Hao W; Ye D
    World J Surg Oncol; 2018 Mar; 16(1):42. PubMed ID: 29499699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of CHD5 hypermethylation in laryngeal squamous cell carcinoma.
    Wang J; Chen H; Fu S; Xu ZM; Sun KL; Fu WN
    Oral Oncol; 2011 Jul; 47(7):601-8. PubMed ID: 21636313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
    Fan L; Zhang A; Deng P
    Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methylation status of uPA promoter in laryngeal squamous cell carcinoma].
    Wang D; Wang T; Ren Z
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 May; 20(9):409-11. PubMed ID: 16836076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chibby is a weak regulator of β-catenin activity in gastric epithelium.
    Li FQ; Chiriboga L; Black MA; Takemaru KI; Raffaniello RD
    J Cell Physiol; 2019 Feb; 234(2):1871-1879. PubMed ID: 30063079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma.
    Huang C; Zhou X; Li Z; Liu H; He Y; Ye G; Huang K
    Mol Med Rep; 2016 Sep; 14(3):2489-96. PubMed ID: 27485791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methylation of promoter and expression of FHIT gene in laryngeal squamous cell carcinoma].
    Yin D; Dong M
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Mar; 19(6):253-5, 258. PubMed ID: 16013507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent transcriptional loss of the PCDH17 tumor suppressor in laryngeal squamous cell carcinoma is partially mediated by aberrant promoter DNA methylation.
    Byzia E; Soloch N; Bodnar M; Szaumkessel M; Kiwerska K; Kostrzewska-Poczekaj M; Jarmuz-Szymczak M; Szylberg L; Wierzbicka M; Bartochowska A; Kalinowicz E; Grenman R; Szyfter K; Marszalek A; Giefing M
    Mol Carcinog; 2018 Jul; 57(7):878-885. PubMed ID: 29566279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation and downregulation of ZNF667-AS1 and ZNF667 promote the malignant progression of laryngeal squamous cell carcinoma.
    Meng W; Cui W; Zhao L; Chi W; Cao H; Wang B
    J Biomed Sci; 2019 Jan; 26(1):13. PubMed ID: 30684967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulated TC1 and downregulated Chibby were correlated with the aberrant β-catenin expression in laryngeal squamous cell carcinoma.
    Ren G; Ma B; Wang J; Xu J; Zhang X; Yin C
    Medicine (Baltimore); 2023 Nov; 102(46):e36066. PubMed ID: 37986347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
    Jili S; Eryong L; Lijuan L; Chao Z
    Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined deletion and DNA methylation result in silencing of FAM107A gene in laryngeal tumors.
    Kiwerska K; Szaumkessel M; Paczkowska J; Bodnar M; Byzia E; Kowal E; Kostrzewska-Poczekaj M; Janiszewska J; Bednarek K; Jarmuż-Szymczak M; Kalinowicz E; Wierzbicka M; Grenman R; Szyfter K; Marszałek A; Giefing M
    Sci Rep; 2017 Jul; 7(1):5386. PubMed ID: 28710449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
    Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
    Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and promoter methylation of Apaf-1 gene in laryngeal squamous cell carcinoma].
    Huang DF; Fu WN; Shang C; Xu ZM; Li ZG; Sun KL
    Yi Chuan Xue Bao; 2004 Dec; 31(12):1327-31. PubMed ID: 15633635
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Shen Z; Zhou C; Li J; Ye D; Deng H; Cao B; Hao W; Lin L; Zhang Y
    Biomed Res Int; 2017; 2017():9058749. PubMed ID: 28299336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.